Johnson & Johnson vs. Atrium Therapeutics, Inc. Common Stock
Johnson & Johnson and Atrium Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | RNA | |
|---|---|---|
| Market Cap | $644.22 billion | $133.77 million |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | RNA | |
|---|---|---|
| Dividend Yield | 2.03% | — |
JNJ and RNA split the dividend factors evenly.
Risk & Sentiment
| JNJ | RNA | |
|---|---|---|
| Short Interest | 0.67% | 0.00% |
RNA leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, RNA overview, RNA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.